; (B) clinical and analytical experts with relevant expertise; (C) beneficiaries; and (D) foreign health insurance system experts. (3) Program considerations In consultation with stakeholders as identified in subsection (b)(2), the Secretary shall issue guidance on— (A) the guidelines to ensure the usage of medications and equipment that are of acceptable quality relative to American quality standards; (B) ways to ensuring quality of care